Hospira recalled two drugs for the second because of manufacturing defects that prompted an April 12 warning letter from the U.S. Food and Drug Administration, said Dan Rosenberg, a company spokesman.
The drugs -- Propofol and Liposyn -- were recalled on April 1, 2010. The company told the FDA the products had been contaminated by particulates during the manufacturing process, he said. The drugs are sold to hospitals and doctors.
The company recalled Propofol and Liposyn in late 2009 because of an equipment failure at a manufacturing facility in Clayton, North Carolina. The FDA inspected the Clayton plant in January and February.